BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27260938)

  • 1. Resuming anticoagulant therapy after intracerebral bleeding.
    Becattini C; Sembolini A; Paciaroni M
    Vascul Pharmacol; 2016 Sep; 84():15-24. PubMed ID: 27260938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.
    Eckman MH; Rosand J; Knudsen KA; Singer DE; Greenberg SM
    Stroke; 2003 Jul; 34(7):1710-6. PubMed ID: 12805495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation Resumption After Intracerebral Hemorrhage.
    Li YG; Lip GYH
    Curr Atheroscler Rep; 2018 May; 20(7):32. PubMed ID: 29781063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?
    Paciaroni M; Agnelli G
    Thromb Haemost; 2014 Jan; 111(1):14-8. PubMed ID: 24258528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis.
    Zhou Z; Yu J; Carcel C; Delcourt C; Shan J; Lindley RI; Neal B; Anderson CS; Hackett ML
    BMJ Open; 2018 May; 8(5):e019672. PubMed ID: 29764874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
    Vestergaard AS; Skjøth F; Lip GY; Larsen TB
    Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of oral anticoagulation related intracerebral hemorrhage].
    Sembill JA; Kuramatsu JB; Hohnloser SH; Huttner HB
    Herz; 2019 Jun; 44(4):315-323. PubMed ID: 30941474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?
    Eckman MH; Wong LK; Soo YO; Lam W; Yang SR; Greenberg SM; Rosand J
    Stroke; 2008 Dec; 39(12):3308-15. PubMed ID: 18845797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage.
    Grainger BT; McFadyen JD; Tran H
    J Thromb Haemost; 2024 Mar; 22(3):594-603. PubMed ID: 37913910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
    Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
    J Med Econ; 2015 Jun; 18(6):399-409. PubMed ID: 25586203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage.
    Murphy MP; Kuramatsu JB; Leasure A; Falcone GJ; Kamel H; Sansing LH; Kourkoulis C; Schwab K; Elm JJ; Gurol ME; Tran H; Greenberg SM; Viswanathan A; Anderson CD; Schwab S; Rosand J; Shi FD; Kittner SJ; Testai FD; Woo D; Langefeld CD; James ML; Koch S; Huttner HB; Biffi A; Sheth KN
    Stroke; 2018 Nov; 49(11):2652-2658. PubMed ID: 30355194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
    Simonsen CZ; Steiner T; Tietze A; Damgaard D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e133-4. PubMed ID: 24103671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Net clinical benefit of anticoagulation for atrial fibrillation following intracerebral hemorrhage.
    Pappas MA; Burke JF
    Vasc Med; 2020 Feb; 25(1):55-59. PubMed ID: 31928394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resumption of Direct Oral Anticoagulants in Patients with Acute Spontaneous Intracerebral Hemorrhage.
    Kato Y; Hayashi T; Suzuki K; Maruyama H; Kikkawa Y; Kurita H; Takao M
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104292. PubMed ID: 31375402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.
    Kuramatsu JB; Gerner ST; Schellinger PD; Glahn J; Endres M; Sobesky J; Flechsenhar J; Neugebauer H; Jüttler E; Grau A; Palm F; Röther J; Michels P; Hamann GF; Hüwel J; Hagemann G; Barber B; Terborg C; Trostdorf F; Bäzner H; Roth A; Wöhrle J; Keller M; Schwarz M; Reimann G; Volkmann J; Müllges W; Kraft P; Classen J; Hobohm C; Horn M; Milewski A; Reichmann H; Schneider H; Schimmel E; Fink GR; Dohmen C; Stetefeld H; Witte O; Günther A; Neumann-Haefelin T; Racs AE; Nueckel M; Erbguth F; Kloska SP; Dörfler A; Köhrmann M; Schwab S; Huttner HB
    JAMA; 2015 Feb; 313(8):824-36. PubMed ID: 25710659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of vitamin K antagonist re-initiation following intracranial hemorrhage in mechanical heart valves: Systematic review and meta-analysis.
    AlKherayf F; Xu Y; Gandara E; Westwick H; Moldovan ID; Wells PS
    Thromb Res; 2016 Aug; 144():152-7. PubMed ID: 27352237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation.
    Maeda K; Koga M; Okada Y; Kimura K; Yamagami H; Okuda S; Hasegawa Y; Shiokawa Y; Furui E; Nakagawara J; Kario K; Nezu T; Minematsu K; Toyoda K;
    J Neurol Sci; 2012 Jan; 312(1-2):82-5. PubMed ID: 21875722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.